Zoetis Stock Drops 36.6% in Six Months, Analysts Highlight Growth and Profitability Strengths

Yahoo Finance··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Zoetis shares have fallen 36.6% over the past six months to $78.46 per share, partly due to softer quarterly results. The company’s constant currency revenue grew at an average annual rate of 8.7% over the last two years, indicating steady global demand. Its five-year average return on invested capital stands at 28.6%, placing it among the most efficient healthcare companies. However, annualized revenue growth over the past five years was a more modest 6.1%, which lags some peers in the sector. The stock now trades at 11.2 times forward earnings.

Impact on assets 2

Health Care▼ · 1 stocks
Zoetis Inc
ZTS
▼ NegativeCapitalrelevance

Stock dropped 36.6% due to softer quarterly results and trades at 11.2x forward earnings

Biotech & Genomic Medicine▲ · 1 stocks
© 2026 MarketIVNews